Recent Advances and Clinical Research in Glaucoma
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".
Deadline for manuscript submissions: closed (25 February 2024) | Viewed by 1451
Special Issue Editor
Special Issue Information
Dear Colleagues,
Glaucoma is one of the leading causes of permanent vision loss. Despite extensive research efforts, there is still limited knowledge on the etiology of this disease and limited therapeutic options. Our treatment strategy is still mainly focused on lowering the intraocular pressure often without acknowledging the patients’ individual risk factors or potential options for a tailored treatment approach. Patients need personalized treatments. This approach should not only be limited to the clinical decisions ophthalmologists make, but take into account everything from single cell interactions to individual influences.
This Special Issue invites research papers that emphasize this idea and try to develop potential individual approaches to enlighten our understanding of the disease and its treatment.
I would like to especially encourage the submission of interdisciplinary works that might help ophthalmologists to obtain other views of this severe disease.
Prof. Dr. Jan Lübke
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glaucoma
- risk factors
- individual treatment
- disease management
- tailored medicine